Wangsu Science & Technology
3
5M
3
0.14
2
- Areas of investment
Summary
Wangsu Science & Technology is the famous Corporate Investor, which was founded in 2000. The fund was located in Asia if to be more exact in China. The main department of described Corporate Investor is located in the Beijing.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Wangsu Science & Technology, startups are often financed by GGV Capital, Microsoft Accelerator Beijing, KTB Ventures. The meaningful sponsors for the fund in investment in the same round are KTB Network, Infotech Ventures, GGV Capital. In the next rounds fund is usually obtained by Redpoint Ventures China, GGV Capital, GF Qianhe Investment.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Retail Technology, Artificial Intelligence. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline FIT2CLOUD, Clobotics
The fund is generally included in less than 2 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2018.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 2
- Rounds per year
- 0.14
- Investments by industry
- Retail Technology (1)
- Computer Vision (1)
- Agriculture (1)
- Analytics (1)
- Machine Learning (1) Show 7 more
- Investments by region
-
- China (3)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 0.33
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Eureka Systems | 20 Sep 2022 | Software, Health Care, Medical | Early Stage Venture | Shanghai, Xuhui, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.